Scorpion Therapeutics

Part of Eli Lilly and Company

CompanyUnited StatesFounded 2020

RORWikidata

Scorpion Therapeutics develops one asset, in phase 1 (Tersolisib in renal insufficiency). Mostly small molecule; based in the United States, founded in 2020.

1
Asset
Furthest stage
Phase 1
Raised
$445M
1
Trial
3
Signals

Pipeline

1
  • Tersolisib

    Selectively inhibits mutant PI3K alpha, blocking signaling that supports tumor growth.

    Phase 1, Small molecule, renal insufficiency

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Funding rounds and grants4
  • People15
  • Signals3
  • Similar companies6

Intelligence